Initiation of empagliflozin treatment enabled weaning of G‐CSF, thereby minimizing risks for myelodysplasia, and acute myeloid leukemia, associated with prolonged G‐CSF use.22, 23. Here, CSF3 is linked to acute myeloid leukemia.